Mutagenicity of derivatives of the oncogenic purine N-oxides.
D000225:Adenine / Q000494:pharmacology; D001412:Bacillus subtilis / Q000187:drug effects; D001973:Bromodeoxyuridine / Q000494:pharmacology; D002273:Carcinogens / Q000494:pharmacology*; D055598:Chemical Phenomena; D002621:Chemistry; D002876:Chromosomes, Bacterial / Q000187:drug effects*; D003497:Cyclic N-Oxides / Q000494:pharmacology; D004269:DNA, Bacterial; D008956:Models, Chemical; D009153:Mutagens; D011687:Purines / Q000494:pharmacology*; D014970:Xanthines / Q000494:pharmacology
D002273:Carcinogens; D003497:Cyclic N-Oxides; D004269:DNA, Bacterial; D009153:Mutagens; D011687:Purines; D014970:Xanthines; C009111:purine N-oxide; D001973:Bromodeoxyuridine; D000225:Adenine